nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefaclor—Haemoglobin—Carmustine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Cefaclor—Urticaria—Teniposide—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Cefaclor—Haemorrhage—Carmustine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Cefaclor—Abdominal pain—Teniposide—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Cefaclor—Body temperature increased—Teniposide—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Cefaclor—Paraesthesia—Fludarabine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Cefaclor—Hallucination—Carmustine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Cefaclor—Sweating—Mitoxantrone—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Cefaclor—Dyspnoea—Fludarabine—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Cefaclor—Haematuria—Mitoxantrone—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Cefaclor—Oedema peripheral—Carmustine—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Cefaclor—Dyspepsia—Fludarabine—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Cefaclor—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Cefaclor—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Cefaclor—Decreased appetite—Fludarabine—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Cefaclor—Hallucination—Vincristine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Cefaclor—Pain—Fludarabine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Cefaclor—Constipation—Fludarabine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Cefaclor—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Cefaclor—Urethral disorder—Vincristine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Cefaclor—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Cefaclor—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Cefaclor—Hypersensitivity—Teniposide—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Cefaclor—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Cefaclor—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Cefaclor—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Cefaclor—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Cefaclor—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Cefaclor—Asthenia—Teniposide—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Cefaclor—Malaise—Bleomycin—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Cefaclor—Pruritus—Teniposide—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Cefaclor—Leukopenia—Bleomycin—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Cefaclor—Body temperature increased—Fludarabine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Cefaclor—Vaginal infection—Methotrexate—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Cefaclor—Cough—Bleomycin—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Cefaclor—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Cefaclor—Diarrhoea—Teniposide—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Cefaclor—Chest pain—Bleomycin—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Cefaclor—Myalgia—Bleomycin—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Cefaclor—Back pain—Carmustine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Cefaclor—Discomfort—Bleomycin—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Cefaclor—Chills—Mitoxantrone—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Cefaclor—Confusional state—Bleomycin—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Cefaclor—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Cefaclor—Tremor—Carmustine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Cefaclor—Oedema—Bleomycin—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Cefaclor—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Cefaclor—Back pain—Vincristine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Cefaclor—Vomiting—Teniposide—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Cefaclor—Agitation—Carmustine—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Cefaclor—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Cefaclor—Asthenia—Fludarabine—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Cefaclor—Rash—Teniposide—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Cefaclor—Dermatitis—Teniposide—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Cefaclor—Headache—Teniposide—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Cefaclor—Pruritus—Fludarabine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Cefaclor—Back pain—Mitoxantrone—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Cefaclor—Leukopenia—Carmustine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Cefaclor—Anorexia—Bleomycin—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Cefaclor—Agitation—Vincristine—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Cefaclor—Hypotension—Bleomycin—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Cefaclor—Diarrhoea—Fludarabine—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Cefaclor—Convulsion—Carmustine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Cefaclor—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Cefaclor—Nausea—Teniposide—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Cefaclor—Vertigo—Vincristine—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Cefaclor—Leukopenia—Vincristine—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Cefaclor—Chest pain—Carmustine—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Cefaclor—Myalgia—Carmustine—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Cefaclor—Anxiety—Carmustine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Cefaclor—Paraesthesia—Bleomycin—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Cefaclor—Malaise—Mitoxantrone—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Cefaclor—Dyspnoea—Bleomycin—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Cefaclor—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Cefaclor—Convulsion—Vincristine—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Cefaclor—Confusional state—Carmustine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Cefaclor—Oedema—Carmustine—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Cefaclor—Decreased appetite—Bleomycin—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Cefaclor—Myalgia—Vincristine—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Cefaclor—Cough—Mitoxantrone—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Cefaclor—Vomiting—Fludarabine—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Cefaclor—Convulsion—Mitoxantrone—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Cefaclor—Rash—Fludarabine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Cefaclor—Dermatitis—Fludarabine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Cefaclor—Pain—Bleomycin—lymphatic system cancer	0.002	0.002	CcSEcCtD
Cefaclor—Thrombocytopenia—Carmustine—lymphatic system cancer	0.002	0.002	CcSEcCtD
Cefaclor—Headache—Fludarabine—lymphatic system cancer	0.002	0.002	CcSEcCtD
Cefaclor—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Cefaclor—Myalgia—Mitoxantrone—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Cefaclor—Chest pain—Mitoxantrone—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Cefaclor—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Cefaclor—Anxiety—Mitoxantrone—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Cefaclor—Discomfort—Mitoxantrone—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Cefaclor—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Cefaclor—Oedema—Vincristine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Cefaclor—Anorexia—Carmustine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Cefaclor—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Cefaclor—Confusional state—Mitoxantrone—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Cefaclor—Nervous system disorder—Vincristine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Cefaclor—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Cefaclor—Hypotension—Carmustine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Cefaclor—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Cefaclor—Oedema—Mitoxantrone—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Cefaclor—Nausea—Fludarabine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Cefaclor—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Cefaclor—Shock—Mitoxantrone—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Cefaclor—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Cefaclor—Urticaria—Bleomycin—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Cefaclor—Anorexia—Vincristine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Cefaclor—Body temperature increased—Bleomycin—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Cefaclor—Insomnia—Carmustine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Cefaclor—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Cefaclor—Paraesthesia—Carmustine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Cefaclor—Hypotension—Vincristine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Cefaclor—Dyspnoea—Carmustine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Cefaclor—Somnolence—Carmustine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Cefaclor—Anorexia—Mitoxantrone—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Cefaclor—Decreased appetite—Carmustine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Cefaclor—Hypotension—Mitoxantrone—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Cefaclor—Insomnia—Vincristine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Cefaclor—Paraesthesia—Vincristine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Cefaclor—Pain—Carmustine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Cefaclor—Constipation—Carmustine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Cefaclor—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Cefaclor—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Cefaclor—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Cefaclor—Decreased appetite—Vincristine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Cefaclor—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Cefaclor—Somnolence—Mitoxantrone—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Cefaclor—Feeling abnormal—Carmustine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Cefaclor—Asthenia—Bleomycin—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Cefaclor—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Cefaclor—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Cefaclor—Pain—Vincristine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Cefaclor—Constipation—Vincristine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Cefaclor—Asthma—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Cefaclor—Pruritus—Bleomycin—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Cefaclor—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Cefaclor—Eosinophilia—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Cefaclor—Pain—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Cefaclor—Constipation—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Cefaclor—Abdominal pain—Carmustine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Cefaclor—Body temperature increased—Carmustine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Cefaclor—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Cefaclor—Pancytopenia—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Cefaclor—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Cefaclor—Dysuria—Methotrexate—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Cefaclor—Neutropenia—Methotrexate—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Cefaclor—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Cefaclor—Abdominal pain—Vincristine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Cefaclor—Body temperature increased—Vincristine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Cefaclor—Urticaria—Mitoxantrone—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Cefaclor—Hypersensitivity—Carmustine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Cefaclor—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Cefaclor—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Cefaclor—Vomiting—Bleomycin—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Cefaclor—Infestation—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Cefaclor—Infestation NOS—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Cefaclor—Rash—Bleomycin—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Cefaclor—Dermatitis—Bleomycin—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Cefaclor—Asthenia—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Cefaclor—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Cefaclor—Hypersensitivity—Vincristine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Cefaclor—Sweating—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Cefaclor—Haematuria—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Cefaclor—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Cefaclor—Epistaxis—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Cefaclor—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Cefaclor—Asthenia—Vincristine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Cefaclor—Diarrhoea—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Cefaclor—Nausea—Bleomycin—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Cefaclor—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Cefaclor—Asthenia—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Cefaclor—Dizziness—Carmustine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Cefaclor—Haemoglobin—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Cefaclor—Diarrhoea—Vincristine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Cefaclor—Hepatitis—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Cefaclor—Haemorrhage—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Cefaclor—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Cefaclor—Urethral disorder—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Cefaclor—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Cefaclor—Vomiting—Carmustine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Cefaclor—Dizziness—Vincristine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cefaclor—Rash—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cefaclor—Dermatitis—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cefaclor—Headache—Carmustine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Cefaclor—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Cefaclor—Vomiting—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Cefaclor—Rash—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Cefaclor—Dermatitis—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Cefaclor—Headache—Vincristine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Cefaclor—Nausea—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Cefaclor—Vomiting—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Cefaclor—Immune system disorder—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cefaclor—Rash—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cefaclor—Dermatitis—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cefaclor—Chills—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Cefaclor—Headache—Mitoxantrone—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Cefaclor—Nausea—Vincristine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Cefaclor—Nausea—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Cefaclor—Back pain—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Cefaclor—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cefaclor—Malaise—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Cefaclor—Vertigo—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Cefaclor—Leukopenia—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Cefaclor—Cough—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Cefaclor—Convulsion—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Cefaclor—Chest pain—Methotrexate—lymphatic system cancer	0.000986	0.000986	CcSEcCtD
Cefaclor—Myalgia—Methotrexate—lymphatic system cancer	0.000986	0.000986	CcSEcCtD
Cefaclor—Arthralgia—Methotrexate—lymphatic system cancer	0.000986	0.000986	CcSEcCtD
Cefaclor—Discomfort—Methotrexate—lymphatic system cancer	0.000975	0.000975	CcSEcCtD
Cefaclor—Confusional state—Methotrexate—lymphatic system cancer	0.000954	0.000954	CcSEcCtD
Cefaclor—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000946	0.000946	CcSEcCtD
Cefaclor—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000927	0.000927	CcSEcCtD
Cefaclor—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000926	0.000926	CcSEcCtD
Cefaclor—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000914	0.000914	CcSEcCtD
Cefaclor—Anorexia—Methotrexate—lymphatic system cancer	0.000901	0.000901	CcSEcCtD
Cefaclor—Hypotension—Methotrexate—lymphatic system cancer	0.000884	0.000884	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000862	0.000862	CcSEcCtD
Cefaclor—Insomnia—Methotrexate—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Cefaclor—Paraesthesia—Methotrexate—lymphatic system cancer	0.000849	0.000849	CcSEcCtD
Cefaclor—Dyspnoea—Methotrexate—lymphatic system cancer	0.000843	0.000843	CcSEcCtD
Cefaclor—Somnolence—Methotrexate—lymphatic system cancer	0.000841	0.000841	CcSEcCtD
Cefaclor—Dyspepsia—Methotrexate—lymphatic system cancer	0.000832	0.000832	CcSEcCtD
Cefaclor—Decreased appetite—Methotrexate—lymphatic system cancer	0.000822	0.000822	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000816	0.000816	CcSEcCtD
Cefaclor—Pain—Methotrexate—lymphatic system cancer	0.000809	0.000809	CcSEcCtD
Cefaclor—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000779	0.000779	CcSEcCtD
Cefaclor—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000773	0.000773	CcSEcCtD
Cefaclor—Urticaria—Methotrexate—lymphatic system cancer	0.000751	0.000751	CcSEcCtD
Cefaclor—Abdominal pain—Methotrexate—lymphatic system cancer	0.000748	0.000748	CcSEcCtD
Cefaclor—Body temperature increased—Methotrexate—lymphatic system cancer	0.000748	0.000748	CcSEcCtD
Cefaclor—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000697	0.000697	CcSEcCtD
Cefaclor—Asthenia—Methotrexate—lymphatic system cancer	0.000678	0.000678	CcSEcCtD
Cefaclor—Pruritus—Methotrexate—lymphatic system cancer	0.000669	0.000669	CcSEcCtD
Cefaclor—Diarrhoea—Methotrexate—lymphatic system cancer	0.000647	0.000647	CcSEcCtD
Cefaclor—Dizziness—Methotrexate—lymphatic system cancer	0.000625	0.000625	CcSEcCtD
Cefaclor—Vomiting—Methotrexate—lymphatic system cancer	0.000601	0.000601	CcSEcCtD
Cefaclor—Rash—Methotrexate—lymphatic system cancer	0.000596	0.000596	CcSEcCtD
Cefaclor—Dermatitis—Methotrexate—lymphatic system cancer	0.000596	0.000596	CcSEcCtD
Cefaclor—Headache—Methotrexate—lymphatic system cancer	0.000592	0.000592	CcSEcCtD
Cefaclor—Nausea—Methotrexate—lymphatic system cancer	0.000562	0.000562	CcSEcCtD
